10 April 2025 Decision overturns earlier decision allowing generic drug maker to launch version | Dispute centres on ...

Prompter patent issue will provide earlier protection for inventions and could avoid need for Quick Path Information ...

Massachusetts lawsuit claims subsidiary of UK pharma company unlawfully re-patented eculizumab, resulting in overpayments of ...

Texas company launches sweeping lawsuits against five major players, alleging infringement of medical device patents tied to ...

Firm’s chair says Fenwick has been active in market for a long time and “waiting to find the right opportunity to deepen our bench and presence”.

EPO: Biotech innovation strong, while pharma trails behind ...

A new High Court judge will be tasked with the “massive decision” on the plausibility of Bristol Myers Squibb’s key anticoagulant patent, following its appeal over failures in the previous trial, say ...

New partner brings 16 years of experience in biotechnology and pharmaceutical patent prosecution to Chicago | Regularly advises on animal biotechnology, antibodies and biologics, cell biology, ...

AstraZeneca fends off diabetes generic, for now ...